CAS 26328-53-0: Amoscanate

Amoscanate is an antischistosomal agent, which is a synthetic compound with a broad spectrum of activity against parasitic infections. Its mode of action involves the disruption of parasite metabolism and structure, ultimately leading to the elimination of schistosomes. Schistosomes are trematode worms responsible for schistosomiasis, a significant parasitic disease affecting millions of people worldwide. In terms of its applications, Amoscanate is primarily used in the treatment and management of schistosomiasis, where it targets both the adult and larval stages of the parasite. The synthetic origin of Amoscanate allows for precise adjustments in its chemical structure, optimizing efficacy and minimizing adverse effects. Research on its mechanism indicates that Amoscanate interferes with key biological pathways within the parasite, thereby eradicating the infection. While its current use might be focused on helminthic diseases, ongoing studies aim to elucidate additional therapeutic potential. The growing interest in this compound underscores the need for novel therapies in the treatment of neglected tropical diseases.

Amoscanate is an antiparasitic agent. It is highly effective in animals against the four major species of schistosomes which infect humans.